ClinVar Miner

Submissions for variant NM_003722.5(TP63):c.1799G>A (p.Gly600Asp)

dbSNP: rs1553863660
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000655482 SCV000777412 pathogenic TP63-Related Spectrum Disorders 2020-12-16 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individual(s) with clinical features of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (PMID: 22329826, 20491771, 16190990, Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as G506D and p.Gly561Asp. ClinVar contains an entry for this variant (Variation ID: 544362). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with aspartic acid at codon 600 of the TP63 protein (p.Gly600Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.